STATUS QWO : CELLULITE HAS MET ITS MATCH WITH A NEW INJECTIBLE
Photo Credit: pexels.com
Cellulilte is one of those topics that most of us in the aesthetics space tend to be leery of. We’ve heard it all before; reduces dimples, pulverizes lumps and bumps, smooths skin, yada, yada, yada. These miracle cures often come with some discomfort, more downtime than expected, a longterm commitment to maintain the improvement, and a hefty price tag. Nonetheless, ‘cellulite’ continues to be a beauty buzzword that gets our attention because 80-90 percent of women, depending on who you ask, have it somewhere.
Enter QWO
The long awaited first-ever cellulite injectable, called QWO from Endo Pharmaceuticals (collagenase clostridium histolyticum-aaes) now has FDA approval, and the data is
FROM THE CLINIC TO THE JAR – MEDICAL AESTHETICS TRENDS
Medical aesthetics continue to evolve as the world of advanced skincare and anti-aging treatments matures. From skin tightening devices to “liquid facelifts,†these new technologies were explored during a robust panel of experts held at the recent HBA Expo in New York City. Entitled “The Present and Future of Medical Aesthetics: Trends from the Clinic to the Jar,†the panel members discussed how non-surgical methods are impacting retail trends and consumers.
“The medical aesthetics category continues to explode as consumers around the world seek the latest in injectables, active cosmetics, skin lightening and at-home devices. The global market is expected t
